Fani Tagaraki

Neuronal pentraxin receptor-1 is a new cerebrospinal fluid biomarker of Alzheimer’s disease progression

M. Tsolaki, E. Diamandis, Ioulietta Lazarou, 2018, F1000Research.

Liquid biopsy of cerebrospinal fluid identifies neuronal pentraxin receptor (NPTXR) as a biomarker of progression of Alzheimer’s disease

M. Tsolaki, E. Diamandis, I. Prassas, 2019, Clinical chemistry and laboratory medicine.